CD44 and Miyoshi myopathy: To evaluate the effect of IFN treatments on the MM CSCs properties, A375 and MEL-1 secondary spheres were characterized by measurement of specific markers expression such as CD20, CD44 and CD133, and ALDH1 activity, in presence and absence of IFN-α (Figure 2).